Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123733074 | 12373307 | 4 | F | 20160507 | 20160701 | 20160516 | 20160707 | EXP | DE-ACTELION-A-US2016-136286 | ACTELION | 56.00 | YR | A | M | Y | 0.00000 | 20160707 | OT | DE | ES |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123733074 | 12373307 | 1 | PS | VENTAVIS | ILOPROST | 1 | Respiratory (inhalation) | 1 DF, QID | 21779 | INHALATION VAPOUR, SOLUTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123733074 | 12373307 | 1 | Pulmonary hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123733074 | 12373307 | DE |
| 123733074 | 12373307 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123733074 | 12373307 | Disease progression | |
| 123733074 | 12373307 | Drug dose omission | |
| 123733074 | 12373307 | Product use issue | |
| 123733074 | 12373307 | Pulmonary hypertension | |
| 123733074 | 12373307 | Respiratory disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123733074 | 12373307 | 1 | 20111001 | 0 |